ZEPZELCA subst sèche 4 mg flac
7680677290015
CH-67729
L01XX69
07.16.1.
Reimbursement limitations:
ZEPZELCA.01
Après garantie de prise en charge des coûts par l’assurance maladie après consultation préalable du …
1 / 3
google
Details
- Product number
- 6772901
- CPT
- -
- Packaging group
- -
- Unit
- Durchstechflasche(n)
- Composition
- lurbinectedinum 4 mg, saccharum, acidum lacticum, natrii hydroxidum corresp. natrium 2.94 mg, pro vitro.
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.94 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5790.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2023
Authorization holder
PharmaMar AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67729
- Drug name
- Zepzelca, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- L01XX69
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 07/03/2023
- Authorization expiration date
- 30/06/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ZEPZELCA subst sèche 4 mg flac
- Description (DE)
- ZEPZELCA Trockensub 4 mg Durchstf
- Market launch
- 07/03/2023
- Narcotic (BTM)
- No